Nasivin Classic Tartósítószermentes (Oxymetazoline Hydrochloride)

Oxymetazoline hydrochloride, the active ingredient in Nasivin Classic Tartósítószermentes, is a alpha‑adrenergic agonist presented as a nasal decongestant for nasal use. It relieves nasal congestion associated with the common cold, sinusitis and allergic rhinitis in adults and children.

GNH USA supplies Nasivin Classic Tartósítószermentes as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxymetazoline hydrochloride acts on the nasal vasculature to alleviate congestion caused by various upper‑respiratory conditions. - Common cold nasal congestion: reduces swelling of nasal mucosa to improve airflow. - Sinusitis‑related congestion: helps clear blocked sinuses and eases breathing. - Allergic rhinitis: diminishes nasal swelling and discharge associated with allergic triggers.

Oxymetazoline nasal spray may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nasal irritation or burning sensation - Dryness of the nasal mucosa - Sneezing - Headache - Altered taste sensation - Mild epistaxis (nosebleed)

Serious or Rare Side Effects: - Rebound nasal congestion with prolonged use - Hypertension or elevated blood pressure - Cardiac arrhythmias - Severe allergic reaction (anaphylaxis) - Nasal ulceration or perforation - Vision disturbances

Before using Oxymetazoline nasal spray, consider the following safety measures. - Pregnancy: consult a healthcare professional before use. - Age restrictions: not recommended for children under 6 years. - Cardiovascular disease: use with caution in patients with hypertension or heart conditions. - Concomitant sympathomimetic drugs: avoid combining with other nasal decongestants. - Duration of use: limit to the recommended period to prevent rebound congestion. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Oxymetazoline may interact with other medications, requiring attention to avoid adverse effects.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Other nasal decongestants: additive vasoconstriction may increase side‑effects. - Sympathomimetic agents (e.g., ephedrine): heightened cardiovascular stimulation.

Moderate Interactions (Monitor Closely): - Antihypertensive drugs: possible reduction in blood‑pressure‑lowering effect. - Beta‑blockers: may blunt cardiovascular response. - Tricyclic antidepressants: potential for increased systemic effects.